Med Ed Report briefs: December 2012

Med Ed Report briefs: December 2012
Med Ed Report briefs: December 2012

Drugmaker Vivus said it's making education a priority during the launch of obesity drug Qsymia. The effort has included peer influence and dinner events, about 200 Qsymia speakers and about 400 speaker program events in 4Q12. A satellite broadcast in October had over 800 participants, and Vivus has had a presence in nine key medical society meetings, the firm said.

India's income tax department is cracking down on expensive gifts from pharma companies to doctors in that country, reports Forbes India. New rules bar drug firms from hiding payments for foreign trips by categorizing them on their balance sheets as marketing expenses.

New requirements for accrediting live CME/CPD events in Europe take effect this month. The European Accreditation Council for CME's rules were set by the ­European Union of Medical Specialists in October.

Writing in the Journal of General Internal Medicine, a postdoc fellow at Johns Hopkins University School of Medicine argues that some physicians use social media sites to discuss treatments or give advice to patients without disclosing information, like drug industry ties, that may bias their opinions.
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters

Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.